 |
 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Rituxan.
No reviews have yet been submitted. Be the first to review this drug.
Medical Encyclopedia:
Pfizer to Continue Evaluation of Inotuzumab Ozogamicin in Other Hematologic Malignancies NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today the...
Data Evaluating WF10's Therapeutic Impact on Signs and Symptoms of Experimentally Induced Rheumatoid Arthritis in Mice MISSISSAUGA, ON, May 16, 2013 /CNW/ -...
Regimen Achieves 97 Percent Overall Response Rate with Estimated Progression-Free Survival at 24 Months of 93 Percent -- -- Results from Study 101-08 and...
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated May 16th, 2013), Cerner Multum™ (updated May 20th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
